Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer

Authors

M Falcinelli, University of Brighton
G Al-Hity, University of Brighton
S Baron, University of Brighton
M Mampay, University of Brighton
M C Allen, University of Brighton
M Samuels, University of Sussex
W Jones, University of Sussex
C Cilibrasi, University of Sussex
Renee L Flaherty, Institute of Cancer Research
G Giamas, University of Sussex
P H Thaker, Washington University School of Medicine in St. Louis
M S Flint, University of Brighton

Journal

Brain, Behavior, and Immunity

Publication Date

5-1-2023

Volume

110

First Page

1

Last Page

12

Document Type

Open Access Publication

DOI

10.1016/j.bbi.2023.02.011

Rights and Permissions

Falcinelli M, Al-Hity G, Baron S, Mampay M, Allen MC, Samuels M, Jones W, Cilibrasi C, Flaherty RL, Giamas G, Thaker PH, Flint MS. Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer. Brain Behav Immun. 2023 May;110:1-12. doi: 10.1016/j.bbi.2023.02.011. © 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Falcinelli, M; Al-Hity, G; Baron, S; Mampay, M; Allen, M C; Samuels, M; Jones, W; Cilibrasi, C; Flaherty, Renee L; Giamas, G; Thaker, P H; and Flint, M S, "Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer." Brain, Behavior, and Immunity. 110, 1 - 12. (2023).
https://digitalcommons.wustl.edu/oa_4/2318

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.